Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Boursier

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Clinics and Research in Hepatology and Gastroenterology|April 29, 2019
Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricksFloraine Zuberbuhler, Jerome Boursier
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2022
ReplyMarine Roux, Jerome Boursier
Gut|March 30, 2020
Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?Andreas Geier, Jerome Boursier
The Journal of Clinical Endocrinology and Metabolism|May 19, 2025
Non-invasive tests developed using artificial intelligence for screening in MASLD: interest and pitfallsJerome Boursier, Bertrand Cariou
Plos Pathogens|January 28, 2015
Implication of gut microbiota in nonalcoholic fatty liver diseaseJerome Boursier, Anna Mae Diehl
JHEP Reports : Innovation in Hepatology|March 4, 2021
Case-finding strategies in non-alcoholic fatty liver diseaseJerome Boursier, Emmanuel A Tsochatzis
Clinics in Liver Disease|April 12, 2016
Nonalcoholic Fatty Liver Disease and the Gut MicrobiomeJerome Boursier, Anna Mae Diehl
Hepatology (Baltimore, Md.)|December 17, 2021
Determinants of the severity of fatty liver diseases: Need all the pieces to solve the puzzleHélène Pailhoriès, Jerome Boursier, Anna Mae Diehl
Journal of Hepatology|May 20, 2020
Reply to: "Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward"Jeremie Riou, Clemence M Canivet, Jerome Boursier
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2013
Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compoundsJerome Boursier, John F Rawls, Anna Mae Diehl
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Clinics and Research in Hepatology and Gastroenterology|April 29, 2019
Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricksFloraine Zuberbuhler, Jerome Boursier
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2022
ReplyMarine Roux, Jerome Boursier
Gut|March 30, 2020
Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?Andreas Geier, Jerome Boursier
The Journal of Clinical Endocrinology and Metabolism|May 19, 2025
Non-invasive tests developed using artificial intelligence for screening in MASLD: interest and pitfallsJerome Boursier, Bertrand Cariou
Plos Pathogens|January 28, 2015
Implication of gut microbiota in nonalcoholic fatty liver diseaseJerome Boursier, Anna Mae Diehl
JHEP Reports : Innovation in Hepatology|March 4, 2021
Case-finding strategies in non-alcoholic fatty liver diseaseJerome Boursier, Emmanuel A Tsochatzis
Clinics in Liver Disease|April 12, 2016
Nonalcoholic Fatty Liver Disease and the Gut MicrobiomeJerome Boursier, Anna Mae Diehl
Hepatology (Baltimore, Md.)|December 17, 2021
Determinants of the severity of fatty liver diseases: Need all the pieces to solve the puzzleHélène Pailhoriès, Jerome Boursier, Anna Mae Diehl
Journal of Hepatology|May 20, 2020
Reply to: "Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward"Jeremie Riou, Clemence M Canivet, Jerome Boursier
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 1, 2013
Obese humans with nonalcoholic fatty liver disease display alterations in fecal microbiota and volatile organic compoundsJerome Boursier, John F Rawls, Anna Mae Diehl
Pageof 7